| Increased global integration in the brain after psilocybin therapy for depression RE Daws, C Timmermann, B Giribaldi, JD Sexton, MB Wall, D Erritzoe, ... Nature medicine 28 (4), 844-851, 2022 | 291 | 2022 |
| Associations between lifetime classic psychedelic use and markers of physical health O Simonsson, JD Sexton, PS Hendricks Journal of Psychopharmacology 35 (4), 447-452, 2021 | 56 | 2021 |
| Population survey data informing the therapeutic potential of classic and novel phenethylamine, tryptamine, and lysergamide psychedelics JD Sexton, CD Nichols, PS Hendricks Frontiers in psychiatry 10, 896, 2020 | 39 | 2020 |
| Prevalence and epidemiological associates of novel psychedelic use in the United States adult population JD Sexton, MS Crawford, NW Sweat, A Varley, EE Green, PS Hendricks Journal of psychopharmacology 33 (9), 1058-1067, 2019 | 33 | 2019 |
| Understanding barriers and facilitators to providing evidence-based care for co-morbid chronic pain and opioid use disorder: An exploratory qualitative study. A Varley, S Lappan, J Jackson, J Sexton, P Hendricks 11 th Annual Conference on the Science of Dissemination and Implementation, 2018 | | 2018 |
| Psychedelic Research: A Review of Clinical Progression JD Sexton Inquiro, the UAB undergraduate science research journal 2017 (10), 10, 2017 | | 2017 |
Peter S. HendricksProfessor, University of Alabama at Birmingham School of Public Health在 uab.edu 的电子邮件经过验证
